Strategic High-Precision Healthcare Solutions for the Lusophone Market & Global Compliance Standards
Send Inquiry NowPortugal’s healthcare sector, anchored by the Serviço Nacional de Saúde (SNS) and a rapidly expanding private hospital network (such as CUF and Luz Saúde), is undergoing a profound digital and infrastructural transformation. As of 2024, the Portuguese medical device market is characterized by a strong demand for high-quality consumables and advanced diagnostic tools. The country has become a strategic hub for the "Health Cluster Portugal," focusing on "Smart Health" and biotechnology.
With an aging population (Portugal has one of the highest aging indexes in Europe), there is a critical "Information Gain" necessity in providing devices that support chronic disease management, respiratory therapy, and long-term urological care. Our engagement in the Portuguese market focuses on bridging the gap between high-volume manufacturing efficiency and the strict regulatory requirements set by INFARMED (National Authority of Medicines and Health Products).
Globally, the medical device industry is pivoting toward sustainability and MDR (Medical Device Regulation) 2017/745 compliance. For Portuguese distributors, sourcing from China-based partners like Jiangxi Serum Pharma Industries Co., Ltd. requires more than just a product; it requires a deep understanding of the Technical File, Clinical Evaluation Reports (CER), and Post-Market Surveillance (PMS). Our 10-year export history ensures that every consumable, from aspiratory tubes to foley catheters, meets the rigorous safety benchmarks expected in the EU zone.
Established Expertise
Global Cooperation Clients
Annual Sales (USD)
Compliant Standards
Jiangxi Serum Pharma Industries Co., Ltd. stands as a beacon of reliability for Portuguese pharmaceutical and nutritional sectors. For nearly a decade, we have perfected the export of biological products, vaccines, and medical consumables. Our unique value proposition lies in our E-E-A-T credentials: we don't just supply; we consult on supply chain optimization for the Lusophone market.
Entering the Portuguese market requires adherence to specific "Local Support" protocols. We provide:
The medical device industry is moving beyond basic functionality. Our roadmap for the Portuguese market includes:
Enhancing stability for injectable solutions in Portuguese emergency rooms.
Advanced molecular structures for better API bioavailability.
Sustainable plant-based ingredients for the Algarve wellness industry.
Yes, all our medical consumables exported to the EU, including Portugal, strictly adhere to the CE certification requirements and are transitioning to meet the new MDR (EU) 2017/745 standards.
Typically, for standard orders of catheters or tubes, the production lead time is 15-20 days, followed by 30-35 days for sea freight. We also offer air freight for urgent pharmaceutical needs reaching Lisbon in 5-7 days.
Absolutely. We provide full documentation including GMP, BP/USP/EP standards, and COA (Certificate of Analysis) for all our active pharmaceutical ingredients and injections.
Yes, we offer customization in Pre-Mix and Co-Crystallization, especially for plant proteins and oils like Squalene or Walnut peptides, tailored to the specific health-food regulations in Portugal.
